Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
Clinical trial NCT04717700 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04717700
- Sponsor
- Ida Bruun Kristensen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2025-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.